Thus, considering the significant effectiveness of antifolate therapies in cancer and the crucial role of MTR in sustaining tumor folate levels, exploring the targeting of MTR, either alone or in conjunction with other antifolates, is an area that needs future exploration to understand its potential effectiveness in cancer treatment. The gene discussed is MTR; the disease is neoplasm.